BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 30427880)

  • 1. Development and validation of warning system of ventricular tachyarrhythmia in patients with heart failure with heart rate variability data.
    Au-Yeung WM; Reinhall PG; Bardy GH; Brunton SL
    PLoS One; 2018; 13(11):e0207215. PubMed ID: 30427880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations for the programming of implantable cardioverter-defibrillators in New Zealand.
    Webber MR; Stiles MK
    Heart Lung Circ; 2012 Dec; 21(12):765-77. PubMed ID: 22926144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac death.
    Au-Yeung WT; Reinhall PG; Poole JE; Anderson J; Johnson G; Fletcher RD; Moore HJ; Mark DB; Lee KL; Bardy GH
    Heart Rhythm; 2015 Oct; 12(10):2058-66. PubMed ID: 26096609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable cardioverter-defibrillator shocks: epidemiology, outcomes, and therapeutic approaches.
    Borne RT; Varosy PD; Masoudi FA
    JAMA Intern Med; 2013 May; 173(10):859-65. PubMed ID: 23546173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of Sudden Cardiac Death in Implantable Cardioverter Defibrillators: A Review and Comparative Study of Heart Rate Variability Features.
    Parsi A; O'Loughlin D; Glavin M; Jones E
    IEEE Rev Biomed Eng; 2020; 13():5-16. PubMed ID: 31021774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of a convolutional neural network for predicting the occurrence of ventricular tachyarrhythmia using heart rate variability features.
    Taye GT; Hwang HJ; Lim KM
    Sci Rep; 2020 Apr; 10(1):6769. PubMed ID: 32317680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.
    Whang W; Mittleman MA; Rich DQ; Wang PJ; Ruskin JN; Tofler GH; Muller JE; Albert CM;
    Circulation; 2004 Mar; 109(11):1386-91. PubMed ID: 14993132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multipole analysis of heart rate variability as a predictor of imminent ventricular arrhythmias in ICD patients.
    Rozen G; Kobo R; Beinart R; Feldman S; Sapunar M; Luria D; Eldar M; Levitan J; Glikson M
    Pacing Clin Electrophysiol; 2013 Nov; 36(11):1342-7. PubMed ID: 23713754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low inappropriate shock rates in patients with single- and dual/triple-chamber implantable cardioverter-defibrillators using a novel suite of detection algorithms: PainFree SST trial primary results.
    Auricchio A; Schloss EJ; Kurita T; Meijer A; Gerritse B; Zweibel S; AlSmadi FM; Leng CT; Sterns LD;
    Heart Rhythm; 2015 May; 12(5):926-36. PubMed ID: 25637563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How the S-ICD (subcutaneous implantable cardiac defibrillator) senses cardiac signals to minimize cardiac over-sensing and maximize rhythm discrimination.
    Brisben A
    J Electrocardiol; 2018; 51(6S):S38-S43. PubMed ID: 30220546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients: Insight From the Resynchronization in Ambulatory Heart Failure Trial.
    Sapp JL; Parkash R; Wells GA; Yetisir E; Gardner MJ; Healey JS; Thibault B; Sterns LD; Birnie D; Nery PB; Sivakumaran S; Essebag V; Dorian P; Tang AS
    Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28292754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting electrical storms by remote monitoring of implantable cardioverter-defibrillator patients using machine learning.
    Shakibfar S; Krause O; Lund-Andersen C; Aranda A; Moll J; Andersen TO; Svendsen JH; Petersen HH; Igel C
    Europace; 2019 Feb; 21(2):268-274. PubMed ID: 30508072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approach to reduction of ventricular arrhythmias and implantable cardioverter-defibrillator therapies in patients with heart failure.
    Sengupta J; Abdelhadi R
    Curr Opin Cardiol; 2013 May; 28(3):337-43. PubMed ID: 23549236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of a curtailed randomized controlled trial, evaluating the efficacy and safety of azimilide in patients with implantable cardioverter-defibrillators: The SHIELD-2 trial.
    Robinson VM; Bharucha DB; Mahaffey KW; Dorian P; Kowey PR;
    Am Heart J; 2017 Mar; 185():43-51. PubMed ID: 28267474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ablation of ventricular arrhythmia in patients with heart failure.
    Chik WW; Marchlinski FE
    Heart Fail Clin; 2015 Apr; 11(2):319-36. PubMed ID: 25834978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal Medications and Appropriate Implantable Cardioverter-defibrillator Shocks in Aborted Sudden Cardiac Death Due to Coronary Spasm.
    Sueda S; Kohno H
    Intern Med; 2018 May; 57(10):1361-1369. PubMed ID: 29321418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?
    Ellenbogen KA; Levine JH; Berger RD; Daubert JP; Winters SL; Greenstein E; Shalaby A; Schaechter A; Subacius H; Kadish A;
    Circulation; 2006 Feb; 113(6):776-82. PubMed ID: 16461817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients treated with catheter ablation for ventricular tachycardia after an ICD shock have lower long-term rates of death and heart failure hospitalization than do patients treated with medical management only.
    Bunch TJ; Weiss JP; Crandall BG; Day JD; May HT; Bair TL; Osborn JS; Mallender C; Fischer A; Brunner KJ; Mahapatra S
    Heart Rhythm; 2014 Apr; 11(4):533-40. PubMed ID: 24333283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.